Uno Healthcare NigeriaUno Healthcare Nigeria
Sultiam (Sutiam) Sultiame 200mg – Treatment for Childhood Epilepsy and Partial Seizures

Origin

Germany

Sultiam (Sutiam) Sultiame 200mg – Treatment for Childhood Epilepsy and Partial Seizures

Sultiam, also known as Sulthiame and marketed under the brand name Ospolot, is a sulfonamide derivative primarily used as an anticonvulsant medication for treating epilepsy in certain countries. It has also shown potential in recent studies for the treatment of obstructive sleep apnea (OSA).

Product Specifications

Active Ingredient
Sultiame
Indication
Benign Epilepsy with Centrotemporal Spikes (BECTS): Also known as Rolandic epilepsy, Sultiame has become the first-line treatment for this common form of childhood epilepsy in some countries. Focal and Partial Seizures: Sultiame is indicated for the treatment of partial seizures, and several studies have explored its potential in managing drug-resistant paediatric epilepsy.
Strength
200mg
Packaging
50 tablets
Storage Temperature
Controlled room temperature

Related Products

Ospolot (Sulthiame) Sultiame 200mg – anticonvulsant for epilepsy
Neurology
View Product

Ospolot (Sulthiame) Sultiame 200mg – anticonvulsant for epilepsy

Details
Ospolot (Sutiam) Sultiame 20mg/mL – Treatment of Childhood Epilepsy and Partial Seizures
Neurology
View Product

Ospolot (Sutiam) Sultiame 20mg/mL – Treatment of Childhood Epilepsy and Partial Seizures

Details
Sultiam (Sutiam) Sultiame 100mg – Treatment of Childhood Epilepsy and Partial Seizures
Neurology
View Product

Sultiam (Sutiam) Sultiame 100mg – Treatment of Childhood Epilepsy and Partial Seizures

Details

Why Choose Uno Healthcare?

Quality Assured

All products undergo rigorous quality checks and are sourced from certified manufacturers.

Global Shipping

Reliable logistics partners ensuring safe and timely delivery to your facility.

Expert Support

Dedicated team available to assist with product inquiries and order management.